hiv-infections

Documents about hiv-infections

• Study of the Prevalence of Transmitted HIV-1 Resistance, Viral Diversity, and Cluster Identification in Patients at the Time of HIV-1 Diagnosis#905047ClinicalTrials.gov
• Differentiated Service Delivery for Antiretroviral Therapy#805710ClinicalTrials.gov
• The process of developing an HIV disclosure intervention for youth with perinatally acquired HIV: The HIV Empowering Adults' Decisions to Share - UK/Uganda Project (Heads-Up).#9467PubMed
• Incidence of Human Immunodeficiency Virus-1 (HIV-1) Infection in HIV-1 Uninfected High Risk Men Who Have Sex With Men#826954ClinicalTrials.gov
• Preventing Unplanned Pregnancies in HIV Infected Zambian Couples#830201ClinicalTrials.gov
• Adherence and Risk Behaviour in Patients With HIV Infection Receiving Antiretroviral Therapy#848537ClinicalTrials.gov
• A Study on Amprenavir in Combination With Other Anti-HIV Drugs in HIV-Positive Patients#900756ClinicalTrials.gov
• A Comparison of Emtricitabine and Stavudine Used With Didanosine Plus Efavirenz in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs#906316ClinicalTrials.gov
• Prevalence and Longitudinal Follow-up of Anal Lesions, HPV Infection and Associated Sexually Transmitted Infections Among Men Who Have Sex With Men in Togo.#208501ClinicalTrials.gov
• Effect of Nutritional Intervention on the Lipid Profile of HIV-Positive Patients Who Start HAART: a Randomized Trial#830362ClinicalTrials.gov
• Daily Nevirapine to Prevent Mother to Infant Transmission of HIV#849418ClinicalTrials.gov
• HIV and Hepatitis Care Coordination in Methadone Treatment#851449ClinicalTrials.gov
• A Study of MVA85A, in Asymptomatic Volunteers Infected With TB, HIV or Both#878772ClinicalTrials.gov
• Acupuncture/Moxibustion for Peripheral Neuropathy in HIV#888257ClinicalTrials.gov
• Point of Care STI Testing#889129ClinicalTrials.gov
• Phase I Study of Safety, Tolerability, and Pharmacokinetics of Viracept in HIV-1 Infected Children and Exposed Infants#903388ClinicalTrials.gov
• Comparison of HIV Clinic-based Treatment With Buprenorphine Versus Referred Care in Heroin-dependent Participants#905429ClinicalTrials.gov
• HIV and adolescents: guidance for HIV testing and counselling and care for adolescents living with HIV : annex 11(a): values and preferences: ALHIV survey#381551WHO IRIS
• A Study of Capravirine Plus VIRACEPT Plus Two Nucleoside Reverse Transcriptase Inhibitors in HIV-Infected Patients Who Failed Previous Anti-HIV Treatments#844465ClinicalTrials.gov
• Efficacy of Tenofovir and Emtricitabine in ARV-naive Patients With HIV/HBV Co-infection#860331ClinicalTrials.gov
• A Phase II Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV vCP205 With or Without HIV-1 SF-2 RGP120 in HIV-1 Uninfected Adult Volunteers#356549ClinicalTrials.gov
• The Safety and Effectiveness of Nevirapine Plus Nelfinavir in HIV-1 Infected Patients Who Have Taken Stavudine#810511ClinicalTrials.gov
• Intermittent Preventive Treatment of Malaria in HIV-Seropositive Pregnant Women in Zambia#846601ClinicalTrials.gov
• The Safety and Effectiveness of (+)-Calanolide A in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs#863314ClinicalTrials.gov
• A Phase 1, Randomized, Blinded, Dose-escalation Study of rAAV1-PG9DP Recombinant AAV Vector Coding for PG9 Antibody in Healthy Male Adults.#878809ClinicalTrials.gov
• Supporting Sustained HIV Treatment Adherence After Initiation#882018ClinicalTrials.gov
• Social and Economic Outcomes of HIV/AIDS Care and Treatment in HIV Infected South African Adults#882808ClinicalTrials.gov
• Annex 9: technical guidance update on quality assurance for HIV rapid diagnostic tests#373053WHO IRIS
• Safety and Immune Response to Preventive HIV Immunization With Adenovirus Serotype 5 or 35 Vector#414341ClinicalTrials.gov
• Evaluating Strategies to Reduce Mother-to-Child Transmission of HIV Infection in Resource-Limited Countries#651142ClinicalTrials.gov
• Studies of Influenza Vaccine and Tetanus-Pneumococcal Vaccine in HIV-infected Patients Receiving Interleukin-2#668845ClinicalTrials.gov
• Study of Boosting Strategies After Vaccination With ALVAC-HIV and AIDSVAX® B/E#807095ClinicalTrials.gov
• A Study of Prevalence of the I50L Mutation When ATV Treated Patients Fail the Regimen#849632ClinicalTrials.gov
• Camu Camu in ART-treated People Living with HIV#857953ClinicalTrials.gov
• A Study of 1592U89 and Ethanol When Given Together to HIV-Infected Patients#860310ClinicalTrials.gov
• Rifaximin as a Modulator of Microbial Translocation and Immune Activation#871104ClinicalTrials.gov
• Handheld Computers to Improve Adherence to Anti-HIV Drug Regimens#883302ClinicalTrials.gov
• A Study of Nystatin in HIV-Infected Patients#897488ClinicalTrials.gov
• Treatment Plan to Decrease Drug Exposure in HIV Infected Adolescents#906569ClinicalTrials.gov
• T-20 in HIV Patients With Prior Drug Treatment and/or Resistance to Each of the Three Classes of Anti-HIV Drugs#805763ClinicalTrials.gov
• The Safety and Effectiveness of Cidofovir in the Treatment of Venereal Warts in HIV-Infected Patients#836620ClinicalTrials.gov
• Effectiveness of a New Anti-HIV Drug (AG1549) Plus Viracept (Nelfinavir) Plus Combivir (Zidovudine/Lamivudine) in HIV-Infected Patients#801925ClinicalTrials.gov
• Safety of and Immune Response to a DNA HIV Vaccine (VRC-HIVDNA009-00-VP) in HIV Infected Individuals With Acute HIV Infection#842247ClinicalTrials.gov
• A Phase I Safety and Immunogenicity Study of HIV p17/p24:Ty-VLP in HIV-1 Seronegative Subjects#806023ClinicalTrials.gov
• Safety of and Immune Response to an Adenoviral HIV Vaccine (VRC-HIVADV014-00-VP) With or Without a Plasmid HIV Vaccine (VRC-HIVDNA016-00-VP) in HIV Uninfected Adults#195374ClinicalTrials.gov
• IL7RA rs10491434 polymorphism is related to spontaneous HIV infection control in naïve HIV-infected patients: A retrospective study.#276166Repisalud
• Improving HIV Screening With Nurse-Based Rapid Testing/Streamlined Counseling#807099ClinicalTrials.gov
• The Safety and Effectiveness of Lamivudine Plus Stavudine or Zidovudine in HIV-Infected Patients Who Have Taken Zidovudine#844485ClinicalTrials.gov
• Hepatitis B Virus (HBV) Prevention for Homeless at Risk for HBV/Hepatitis C Virus (HCV)/HIV#872747ClinicalTrials.gov
• Young widowhood as a predictor of HIV risk behaviors in a high HIV prevalence setting in Siaya County, Kenya.#292767PubMed